Serial antipyrine clearance studies detect altered hepatic metabolic function during spontaneous and interferon‐induced changes in chronic hepatitis B disease activity
Stephen J. Williams, Geoffrey C. Farrell – 1 August 1989 – The present study was performed to establish whether sequential determinations of antipyrine clearance, using a simplified two‐point test, are sensitive and specific indicators of changes in chronic hepatitis B disease activity. Sixteen patients were studied on four or more occasions during 18 to 30 months. Eleven patients were treated with recombinant human α‐interferon (2.5, 5.0 or 10 × 106 per m2, intramuscularly, three times per week, for 24 weeks), and five patients were untreated controls.